LB Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 3.35 M | $108.82 M | 0.00% | 11.13% |
| BLACKROCK, INC. | 08/07/2026 | 2.73 M | $88.74 M | 10.66% | 9.07% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 2.21 M | $71.68 M | 0.00% | 7.33% |
| TRAILS EDGE CAPITAL PARTNERS, LP | 08/14/2026 | 1.52 M | $49.43 M | 15.44% | 5.05% |
| COMMODORE CAPITAL LP | 08/14/2026 | 1.50 M | $48.68 M | 0.00% | 4.98% |
| JPMORGAN CHASE & CO | 08/12/2026 | 1.50 M | $48.87 M | 4.88% | 4.97% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 1.45 M | $46.97 M | -21.32% | 4.80% |
| CALIGAN PARTNERS LP | 08/14/2026 | 1.44 M | $46.67 M | 0.00% | 4.77% |
| SPRUCE STREET CAPITAL LP | 08/13/2026 | 1.38 M | $44.66 M | 0.00% | 4.57% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 1.05 M | $34.17 M | 0.00% | 3.49% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 971.17 K | $31.52 M | 8.55% | 3.22% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 921.47 K | $29.91 M | -0.24% | 3.06% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 863.95 K | $28.04 M | 0.00% | 2.87% |
| VIVO CAPITAL, LLC | 08/14/2026 | 800.00 K | $25.96 M | 0.00% | 2.65% |
| NAN FUNG GROUP HOLDINGS LTD | 08/13/2026 | 630.66 K | $20.47 M | 0.00% | 2.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 612.79 K | $19.89 M | 18.25% | 2.03% |
| STATE STREET CORP | 08/07/2026 | 602.03 K | $19.54 M | 19.36% | 2.00% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 585.00 K | $18.99 M | -36.07% | 1.94% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 576.46 K | $18.71 M | 58.45% | 1.91% |
| JENNISON ASSOCIATES LLC | 08/03/2026 | 540.90 K | $17.55 M | 0.50% | 1.79% |
| GREAT POINT PARTNERS LLC | 08/14/2026 | 317.22 K | $10.30 M | 5.74% | 1.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 275.68 K | $8.95 M | 100.00% | 0.91% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 259.22 K | $8.41 M | 89.26% | 0.86% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 227.49 K | $7.38 M | 110.04% | 0.75% |
| CITADEL ADVISORS LLC | 09/02/2026 | 215.97 K | $7.01 M | -48.20% | 0.72% |
| HIGHVISTA STRATEGIES LLC | 08/14/2026 | 211.51 K | $6.86 M | 21.84% | 0.70% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 200.00 K | $6.49 M | 0.00% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 195.49 K | $6.34 M | 5.05% | 0.65% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 195.49 K | $6.34 M | 100.00% | 0.65% |
| FMR LLC | 08/13/2026 | 188.91 K | $6.13 M | -15.10% | 0.63% |
| NORTHERN TRUST CORP | 08/13/2026 | 186.04 K | $6.04 M | 20.49% | 0.62% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 183.66 K | $5.96 M | 83.30% | 0.61% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 162.80 K | $5.28 M | 3.41% | 0.54% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 152.16 K | $4.94 M | 35.26% | 0.50% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2026 | 150.00 K | $4.87 M | 0.00% | 0.50% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 91.66 K | $2.97 M | 100.00% | 0.30% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 86.37 K | $2.80 M | 2,031.56% | 0.29% |
| UBS GROUP AG | 08/13/2026 | 85.95 K | $2.79 M | -37.69% | 0.29% |
| LONGBOW FINANCE SA | 07/29/2026 | 82.34 K | $2.67 M | 100.00% | 0.27% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 70.00 K | $2.27 M | 0.00% | 0.23% |
| NEXTBIO CAPITAL MANAGEMENT LP | 08/14/2026 | 68.25 K | $2.22 M | 100.00% | 0.23% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 58.89 K | $1.91 M | 11.88% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 54.98 K | $1.78 M | 20.95% | 0.18% |
| ALERUS FINANCIAL NA | 08/14/2026 | 54.89 K | $1.78 M | 100.00% | 0.18% |
| NUVEEN, LLC | 08/11/2026 | 52.14 K | $1.69 M | 127.04% | 0.17% |
| MORGAN STANLEY | 08/13/2026 | 51.21 K | $1.66 M | 8.31% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 48.65 K | $1.58 M | 282.48% | 0.16% |
| XTX TOPCO LTD | 08/14/2026 | 47.01 K | $1.53 M | 100.00% | 0.16% |
| Y-INTERCEPT (HONG KONG) LTD | 07/14/2026 | 39.41 K | $1.28 M | 100.00% | 0.13% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 34.07 K | $1.11 M | -52.72% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
LB Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 125 institutional investors and hedge funds held shares of LB Pharmaceuticals Inc. The most heavily invested institutionals were:
Deep Track Capital, LP: 3.35 M
BlackRock, Inc.: 2.73 M
RA CAPITAL MANAGEMENT, L.P.: 2.21 M
Trails Edge Capital Partners, LP: 1.52 M
COMMODORE CAPITAL LP: 1.5 M
JPMORGAN CHASE & CO: 1.5 M
99.39% of LB Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 31.18 M shares in the last 24 months. This purchase volume represents approximately $758.93 M in transactions.